Abstract:Objective To investigate the mechanism of effect of melatonin (N-acetyl-5-metyoxytryptamine,MT) on anti peritoneal dialysis-related peritoneal fibrosis via regulating the TG-β1/Smad pathway.Methods Sixty rats were randomly divided into normal control groupmodel control group,low-,middle-,high-dose drug groups (n =12 each).Except normal control group,peritoneal fibrosis model was established by intraperitoneal injection of peritoneal dialysis solution containing 4.25％ glucose in rats of other groups.After modeling,0.125-,0.5-,2.0-mg · kg-1 · d-1 of MT were respectively given by gavage administration in low-,middle-,high-dose drug groups.In normal control group,equal volume of normal saline was given by intraperitoneal injection.After cultivation for 4 weeks under suitable conditions,the rats were killed,and appropriate amount of peritoneal,intestinal tissues and blood samples were taken.The changes of histopathology of peritoneal and intestinal mucosa and parietal peritoneum thickness were observed after HE and Masson trichrome staining.Immunohistochemical method was used to detect the expressions of transforming growth factor-β1 (TGF-β1),α-smooth muscle action (α-SMA),monocyte chemotactic protein 1 (MCP-1)in peritoneal tissues and Occludin protein in intestinal mucosa.Electrophoretic mobility shift assay(EMSA) was used to detect nuclear factor-kappa B(NF-κB) activity.Enzyme linked immunosorbent assay (ELISA)-sandwich technique was used to detect the concentrations of interleukin-1 (IL-1),tumor necrosis factor (TNF-α).Results The thickness of parietal peritoneum,IL-1 and TNF-α levels in rats of model control group were significantly higher than those in rats of normal control group and low-,middle-,high-dose drug groups (P ＜ 0.05,P ＜ 0.01)which in high-dose drug group were significantly lower than those in model control group and low-,middle-dose drug groups(P ＜ 0.05,P ＜ 0.01).The expression levels of TGF-β1,MCP-1,α-SMA,Occludin protein and NF-κB activity in model control group were significantly higher than those in normal control group and low-,middle-,high-dose drug groups(P ＜0.05,P ＜0.01)which in high-dose drug group were significantly lower than those in model control group and low-,middle-dose drug groups (P ＜ 0.05,P ＜ 0.01).There was no significant difference in α-SMA level between high-dose drug group and normal control group (P ＞ 0.05).Conclusions Peritoneal dialysis solution containing 4.25 ％ glucose by intraperitoneal injection can establish peritoneal fibrosis model.Melatonin can inhibit important intracellular signal regulatory factors TGF-β1 and NF-κB leading to peritoneal fibrosis thus relief peritoneal fibrosis by moderate regulation of TGF-β1/Smad pathway and inhibition of signal transduction of NF-κB.

Low Molecular Weight Heparin (Lmwh) Improves Peritoneal Function And Inhibits Peritoneal Fibrosis Possibly Through Suppression Of Hif-1 Alpha, Vegf And Tgf-Beta 1

Effects of Short Hairpin RNAs on TGF-β1 Expression and Ultrastructure in HPMCs Induced by Peritoneal Dialysis Solution

Functional and structural alterations of peritoneum and secretion of fibrotic cytokines in rats caused by high glucose peritoneal dialysis solutions.

The Protective Effects Of Melatonin On Peritoneal Fibrosis Induced By High Glucose Peritoneal Dialysis In Rats

Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl 4 -Induced Liver Fibrosis.

Pharmacological Inhibition of Heparin-Binding EGF-like Growth Factor Promotes Peritoneal Angiogenesis in a Peritoneal Dialysis Rat Model.

Effect of melatonin on anti peritoneal dialysis-related peritoneal fibrosis by regulating the TG-β1/Smad pathway

Down-regulating the Production of TGF-β1 and Anti-Hepatic Fibrosis by Low Molecular Heparin in Rat

Tanshinone IIA Attenuates Peritoneal Fibrosis Through Inhibition of Fibrogenic Growth Factors Expression in Peritoneum in a Peritoneal Dialysis Rat Model

[The Role of TGF-beta1/Smads in the Development of Peritoneal Fibrosis Induced by High Glucose Peritoneal Dialysate and LPS].

HIF1A and VEGF Regulate Each Other by Competing Endogenous RNA Mechanism and Involve in the Pathogenesis of Peritoneal Fibrosis.

Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice

Hepatocyte Growth Factor-Induced Amelioration in Renal Interstitial Fibrosis is Associated with Reduced Expression of Alpha-Smooth Muscle Actin and Transforming Growth Factor-Beta1.

Low molecular weight heparins promote migration and invasion of trophoblast cells through regulating the PI3K/AKT signaling pathway

Influence of low-molecular-weight heparin on PAI-1 in rats with immune complexes nephritis

Inhibition of PI3K/AKT/mTOR Signalling Pathway Activates Autophagy and Suppresses Peritoneal Fibrosis in the Process of Peritoneal Dialysis

Inhibition Effect Of Small Interfering Rna Of Connective Tissue Growth Factor On The Expression Of Vascular Endothelial Growth Factor And Connective Tissue Growth Factor In Cultured Human Peritoneal Mesothelial Cells

The effect of different dosages of low molecular weight heparin on acute pulmonary embolism and inhibition of pulmonary intimal hyperplasiain immature rats

Effects of exogenous H2S on peritoneal morphological and functional damages in a rat model of peritoneal dialysis

Influence of low molecular weight heparin on the lipometabolism in hemodialysis patients

Level of HIF-1α in Peritoneal Dialysate Effluent of Peritoneal Dialysis Patients and Its Relationship with TGF-β_1、IL-6、CRP and Peritoneal Function